Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
The TRIUMPH-4 Phase 3 data provides the most current safety information: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) versus 0% placebo Decreased appetite: 19.0% (9 mg) to 18.2% (12 mg) versus 9.4% placebo The pattern is clear
The standard escalation runs: 2mg (weeks 1 through 4), 4mg (weeks 5 through 8), 8mg (weeks 9 through 12), and 12mg from week 13 onward as the maintenance dose
It would be best for both doctors and patients to approach its use judiciously until we know more, but the lure of the marketing may make waiting to see a difficult stance to take. There is no suggestion that side-effects of Wegovy have been concealed
In SURMOUNT-1, the most common adverse events at the 15 mg dose included nausea (31%), diarrhea (23%), constipation (11%), and vomiting (12%)
US$ 25.91
US$ 27.45
US$ 21.37
US$ 20.05
US$ 28.47
